The President-elect of the United States of America, Joe Biden, received a Covid-19 vaccine live on television, on Monday.
Biden, 78, received the Pfizer vaccine at the Christiana Hospital in Newark, Delaware.
The live administration of the vaccine was a campaign to encourage Americans to get the new vaccine.
The presidential transition team had earlier confirmed that the the President-elect’s wife, Jill, had received the jab.
“There’s nothing to worry about,” Biden said during the live vaccination.
Biden also encouraged American citizens to “listen to the experts” and regularly wear their face protection masks.
The President-elect now joins the list of high-profile political personalities who have publicly joined the first wave of vaccinations world-wide.
Last week, U.S Vice President, Mike Pence, and his wife, got the covid-19 vaccinations.
Read also: Pfizer Vaccine: FDA Investigating Reports Of Allergic Reactions In Different States
The jab is the first shot in what is a two-stage Pfizer vaccine.
“I am looking forward to it” Biden said ahead of the next and last stage of the vaccine.
Biden went on to hail every scientist and brain behind the vaccine.
“The scientists and the people who put this together — frontline workers, people who were the ones who actually did the clinical work deserve praise,” Biden stated.
To the medical workers, Biden described them as “amazing and incredible.”
By Jan. 20, 2021, President-elect, Joe Biden, will be the oldest president ever to take office.
He defeated current President, Donald Trump, in the recent U,S elections that has since drawn controversy after Trump called out Biden and his team for election rigging among other claims.
Donald Trump has, however, not taken part in the first wave of vaccinations.
The outgoing President claims to have a “natural immunity” after recovering from a bout of coronavirus recently.
He has not issued statements or supported the campaign to encourage Americans get the new vaccine
Trump’s wife, Melania, is another figure who has remained silent on the issue.